Seer Receives Competing Revised Acquisition Proposals from Radoff-JEC Group and CEO Omid Farokhzad
REDWOOD CITY, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today confirmed that on July 28, 2026, it received a further revised, unsolicited, non-binding acquisition proposal from Bradley L.
How this was made
The 30-second read
Why it matters
Traders should focus on offer credibility, any movement toward binding terms, and whether the committee signals preference for a higher price or better CVR economics.
Market read
Fresh competing bid terms for Seer can move the stock and the implied deal spread, especially for M&A arbitrage and event-driven positioning.
What to watch
The presence of a CEO-led proposal can complicate perceptions of process quality and timing, and the contingent value rights structure may affect effective consideration versus headline cash price.
Background
Seer is in an active acquisition process, with the board’s Special Committee reviewing multiple unsolicited proposals.
Ticker impact
Seer confirmed it received competing revised, unsolicited, non-binding acquisition proposals, including $2.55/share from the Radoff-JEC Group and $2.45/share from CEO Omid Farokhzad.
Likely upward bias versus pre-news levels, with volatility driven by which bid is viewed as most credible and whether the board seeks a higher topping offer.
The article discloses fresh, competing proposal terms and that the Special Committee will review both; even though proposals are non-binding, revised cash-per-share offers typically support the stock and can trigger bid competition dynamics.
Market effects
Limited direct sector read-through, but reinforces that proteomics/biotech-adjacent small caps can attract takeover interest.
Minimal, primarily company-specific M&A sentiment.
Low; this is a US-listed issuer-specific acquisition process.
Counterpoint
Non-binding proposals and a board review process can still end without a deal, so the stock may fade if no binding offer emerges.
Key entities
- companySeer, Inc.
Nasdaq-listed proteomics company that received revised unsolicited acquisition proposals.
- acquirer_groupRadoff-JEC Group
Bradley L. Radoff and Michael Torok and affiliates, proposing $2.55/share cash plus a contingent value right.
- executiveOmid Farokhzad
Seer Chair and CEO who submitted a revised unsolicited non-binding proposal at $2.45/share cash plus two CVRs.
- board_committeeSeer Special Committee
Board committee tasked with reviewing both proposals and alternatives; no stockholder action required yet.
